Cypriot company receives major investment to develop microRNA therapeutics
ASBIS and Lanitis Group will invest €1.2 million to help fuel cancer biotech Theramir’s growth and expand its portfolio of stem cell and microRNA-based technologies
Cypriot biotech company Theramir, which ...